日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of bi-weekly cofrogliptin treatment replacing daily dipeptidyl peptidase-4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open-label, randomized controlled phase 2 trial

在中国2型糖尿病患者中,每两周一次的考格列汀治疗替代每日服用二肽基肽酶-4抑制剂的疗效和安全性:一项多中心、开放标签、随机对照II期试验

Pan, Congqing; Jiang, Hongwei; Feng, Yi; Wang, Suijun; Zhang, Jin; Wang, Zhongjing; Zhou, Yusen; Li, Fangqiong; Zhang, Zhanhui; Li, Yaming; Chen, Liming

PCSK9 inhibitors improve lipid profile and hepatic steatosis surrogate indicators in patients with MAFLD and type 2 diabetes

PCSK9抑制剂可改善MAFLD和2型糖尿病患者的血脂谱和肝脂肪变性替代指标。

Zhou, Qingna; Liu, Xiaoxia; Tang, Yunzhao; Pan, Congqing; Bi, Xuena

Treatment in cesarean scar pregnancy: a retrospective cohort study

剖宫产瘢痕妊娠的治疗:一项回顾性队列研究

Li, Congqing; Song, Fei; Wang, Wenyan; Wei, Bing

Clinicopathological characteristics and prognosis of patients with mucinous adenocarcinoma originating from the left colon, right colon, or rectum: a nationwide retrospective study in China

中国一项全国性回顾性研究:起源于左半结肠、右半结肠或直肠的黏液腺癌患者的临床病理特征及预后

Liu, Bingxu; He, Haoqing; Guan, Xu; Zhang, Peng; Liang, Benjia; Sun, Yueming; Yu, Minhao; Ning, Shanglei; Zhang, Yifei; Lv, Yanfeng; Sun, Yanwu; Sun, Qi; Wang, Lei; Liu, Jiangang; Jiao, Meng; Sun, Yanlai; Jiang, Congqing; Ren, Xianghai; Li, Jun; Liu, Dongning; Zhang, Zhao; Ye, Zhibin; Ma, Bin; Yu, Guodong; Fu, Wei; Kong, Xiangheng; Chen, Jingbo; Jing, Changqing; Zhang, Guangyong; Yang, Hui

Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy

T细胞中TRIM25缺失导致VISTA蛋白破坏,从而增强癌症免疫疗法的效果。

Yishuang Sun # ,Zijian Zhang # ,Haiou Li # ,Xia Bu # ,Li Chen # ,Xiyong Wang ,Lifang Fan ,Baoxiang Chen ,Lijun Kong ,Panpan Dai ,Wenjing Song ,Xiangling Xiao ,Jie Shi ,Bolin Xiang ,Chuan He ,Yingmeng Yao ,Wenjun Xiong ,Haisheng Yu ,Congqing Jiang ,Qun Qian ,Hudan Liu ,Sufang Tian ,Guoliang Qing ,Zhiyong Yang ,Wenyi Wei ,Gordon J Freeman ,Haichuan Zhu ,Jinfang Zhang

Isolable zero-valent Ditin(0) and Diplumbum(0) complexes

可分离的零价二锡(0)和二铅(0)配合物

Shen, Jinghang; Zhang, Zhengting; Ke, Xiaokang; Peng, Luming; Zhao, Qianyi; Zhu, Congqing; Zhu, Qin

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

作者更正:ERK 和 USP5 通过去泛素化调控 PD-1 稳态,从而调节肿瘤免疫疗法。

Xiao, Xiangling; Shi, Jie; He, Chuan; Bu, Xia; Sun, Yishuang; Gao, Minling; Xiang, Bolin; Xiong, Wenjun; Dai, Panpan; Mao, Qi; Xing, Xixin; Yao, Yingmeng; Yu, Haisheng; Xu, Gaoshan; Li, Siqi; Ren, Yan; Chen, Baoxiang; Jiang, Congqing; Meng, Geng; Lee, Yu-Ru; Wei, Wenyi; Freeman, Gordon J; Xie, Conghua; Zhang, Jinfang

An unusual chiral-at-metal mechanism for BINOL-metal asymmetric catalysis

BINOL-金属不对称催化中一种不寻常的金属手性机制

Li, Zhenxing; Chen, Pengfei; Ni, Zhigang; Gao, Liuzhou; Zhao, Yue; Wang, Ranran; Zhu, Congqing; Wang, Guoqiang; Li, Shuhua

Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis

破解癌症免疫疗法耐药性的密码:细胞焦亡和坏死性凋亡的新兴作用

Lei, Kunming; Chen, Jiujiu; Deng, Yanrong; Peng, Yige; Zhai, Xiang; Ren, Xianghai; Zhao, Jianhong; Chen, Baoxiang; Jiang, Congqing

Retraction Note: Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion

撤稿声明:CDKL1表达下调抑制神经母细胞瘤细胞增殖、迁移和侵袭

Li, Weiyi; Cao, Jing; Liu, Jian; Chu, Wenli; Zhang, Congqing; Chen, Shuiling; Kang, Zefeng